New Ask Claude or ChatGPT about any stock, using Bullpen. Bullpen in Claude or ChatGPT. 7 days free

Tuesday, November 17, 2026

Back to the front page

From X

Fajasy on X

35% of TOYO Co., Ltd’s $TOYO H1 2026 revenue came from one customer it doesn’t name, and 22% came from companies under its own controlling shareholder. $TOYO manufactures solar cells, the processed silicon wafers that turn sunlight into electricity, and assembles some of them into panels (modules). Its cells use TOPCon (tunnel oxide passivated contact), a common high-efficiency silicon cell design. $TOYO runs three factories: 1) Ethiopia (4 GW of cells): Started production in April 2025, six months after $TOYO announced the plant, added a second 2 GW line in August, and reached its 4 GW nameplate in October 2025. 2) Vietnam (2 GW of cells): Running since H2 2023, but its cells now go to non-U.S. markets like India and Taiwan, since the U.S. Commerce Department set anti-dumping and countervailing duties (taxes on imports sold below cost or subsidized) on Vietnamese cells in April 2025. 3) Texas (2 GW of modules): A leased 567,140-square-foot plant near Houston that started its first 1 GW line in October 2025 and had completed its second by early October 2026. It assembles panels from $TOYO’s Ethiopian cells. VSUN (Vietnam Sunergy JSC) is the Vietnamese panel maker $TOYO was carved out of, and both companies sit under the same majority shareholder, Abalance, a Japanese solar group. VSUN is still $TOYO’s lender, owed $51.4M including interest, and a past wafer supplier through its Chinese subsidiary. $TOYO’s $261.0M of H1 2026 revenue came from four lines: → Third-party cells (56.5%): $147.6M of cells sold to outside module makers. → Related-party sales (22.0%): $57.5M of cells and modules sold to VSUN and its affiliates. → OEM services (14.2%): $37.2M of fees for cells made under one customer’s name, which $TOYO books net, counting only its fee as revenue. → Third-party modules (7.2%): $18.7M of Texas-made panels. Upstream, 70% of the polysilicon (the refined silicon that wafers are cut from) in $TOYO’s Ethiopian cells comes from a U.S. producer and the rest from OCI’s plant in Malaysia, Rhone Resch, $TOYO’s Chief Strategy Officer, said on the Q2 call. Resch also said its 2026 wafers come from non-China production, “including a designated facility in Indonesia.” $TOYO markets its supply chain as “non-FEOC,” free of any foreign entity of concern. U.S. buyers care, since the One Big Beautiful Bill Act (OBBBA) denies the main clean-power tax credit to projects with too much equipment from Prohibited Foreign Entities, a label aimed at Chinese suppliers.

S&P Global

S&P Global’s valuation swung from 7x earnings in 2009 to 50x in 2024 as ratings, indices and proprietary data expanded through acquisitions…

Monte Investments Market Brief Vol. CXXXVI

Monte Investments rotated Nvidia into Alphabet before earnings and reviews Knife River’s margin squeeze, AMD’s World Labs acquisition, and…

Envisioning Entravision

Entravision’s AdTech revenue rose 133% and EBIT 261% in Q3 as management weighs TV-station sales before its TelevisaUnivision agreement…

Bimergen Energy: Research Note

Bimergen Energy reported $3.0 million of Q3 revenue, below estimates, while a $3.6 million fair-value gain lifted net income to $2.4…

TOST · long

Toast INC

Toast is pitched as a long opportunity on its growth runway and margin expansion after recent software and payments underperformance.

Trading Post November 16, 2026

Adobe (ADBE) became a full position at about $246, backed by buybacks and confidence it can adapt to AI competition.

003100.KQ: grain share 25% to 38%

Sun Kwang (003100.KQ) raised grain market share from 25% to 38% as its founding family transferred 24% of the company to holding companies…

Publications we follow

Every publication on this site, hand-picked.

130 publications

Newsletters 110

X accounts we follow

Every account on this site, hand-picked.

91 accounts

Investor letters we follow

383 firms

Sectors

Ordered by how often our editor reaches for them.